138 related articles for article (PubMed ID: 21159060)
1. Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes.
Kaneda A; Yagi K
Cancer Sci; 2011 Jan; 102(1):18-24. PubMed ID: 21159060
[TBL] [Abstract][Full Text] [Related]
2. Three DNA methylation epigenotypes in human colorectal cancer.
Yagi K; Akagi K; Hayashi H; Nagae G; Tsuji S; Isagawa T; Midorikawa Y; Nishimura Y; Sakamoto H; Seto Y; Aburatani H; Kaneda A
Clin Cancer Res; 2010 Jan; 16(1):21-33. PubMed ID: 20028768
[TBL] [Abstract][Full Text] [Related]
3. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.
Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A
Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457
[TBL] [Abstract][Full Text] [Related]
5. Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.
Karpinski P; Szmida E; Misiak B; Ramsey D; Leszczynski P; Bebenek M; Sedziak T; Grzebieniak Z; Jonkisz A; Lebioda A; Sasiadek MM
Mol Carcinog; 2012 Dec; 51(12):1003-8. PubMed ID: 22006538
[TBL] [Abstract][Full Text] [Related]
6. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
Frazier ML; Xi L; Zong J; Viscofsky N; Rashid A; Wu EF; Lynch PM; Amos CI; Issa JP
Cancer Res; 2003 Aug; 63(16):4805-8. PubMed ID: 12941799
[TBL] [Abstract][Full Text] [Related]
7. Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.
Kawakami K; Matsunoki A; Kaneko M; Saito K; Watanabe G; Minamoto T
Cancer Sci; 2011 Jan; 102(1):166-74. PubMed ID: 21087350
[TBL] [Abstract][Full Text] [Related]
8. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
9. Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma.
Yagi K; Takahashi H; Akagi K; Matsusaka K; Seto Y; Aburatani H; Nakajima A; Kaneda A
Am J Pathol; 2012 Feb; 180(2):616-25. PubMed ID: 22115708
[TBL] [Abstract][Full Text] [Related]
10. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype.
Karpinski P; Myszka A; Ramsey D; Misiak B; Gil J; Laczmanska I; Grzebieniak Z; Sebzda T; Smigiel R; Stembalska A; Sasiadek MM
Cancer Epidemiol; 2010 Jun; 34(3):338-44. PubMed ID: 20381446
[TBL] [Abstract][Full Text] [Related]
12. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study.
Van Guelpen B; Dahlin AM; Hultdin J; Eklöf V; Johansson I; Henriksson ML; Cullman I; Hallmans G; Palmqvist R
Cancer Causes Control; 2010 Apr; 21(4):557-66. PubMed ID: 20012180
[TBL] [Abstract][Full Text] [Related]
13. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
14. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of colorectal cancer: Implications for cancer control.
Jass JR
Surg Oncol; 2007 Dec; 16 Suppl 1():S7-9. PubMed ID: 18023574
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer.
Worthley DL; Whitehall VL; Buttenshaw RL; Irahara N; Greco SA; Ramsnes I; Mallitt KA; Le Leu RK; Winter J; Hu Y; Ogino S; Young GP; Leggett BA
Oncogene; 2010 Mar; 29(11):1653-62. PubMed ID: 19966864
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype.
Gebhard C; Mulet-Lazaro R; Glatz D; Schwarzfischer-Pfeilschifter L; Schirmacher P; Gaedcke J; Weichert W; Reuschel E; Dietmaier W; Rehli M
Int J Cancer; 2022 Feb; 150(4):617-625. PubMed ID: 34591983
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer].
Cai GX; Xu Y; Cai SJ; Shi YQ; Lian P; Peng JJ; Guan ZQ; Du X
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):555-60. PubMed ID: 18000779
[TBL] [Abstract][Full Text] [Related]
19. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer.
Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC
J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
